Wolchok, an internationally acclaimed medical oncologist, will lead a clinical enterprise dedicated to translating groundbreaking discoveries on the underlying causes of cancer into cutting-edge treatment approaches and personalized therapies to improve patient outcomes.
Antibodies that summon white blood cells may play an important role in protecting infants from congenital infection with human cytomegalovirus, according to a study led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian.
Small proteins that direct immune cells toward sites of infection can also form DNA-bound nanoparticles that can induce chronic, dysfunctional immune responses, according to a new study.
A protein called Zbtb46, expressed by specialized immune cells, has a major role in protecting the gastrointestinal tract from excessive inflammation, according to a study from researchers at Weill Cornell Medicine.
New research found that establishing complete trauma care programs accessible to 100% of road injury victims could save the lives of 200,000 people annually.
A three-year, $15 million partnership between Cornell and NewYork-Presbyterian will employ artificial intelligence to help improve outcomes for people with cardiovascular disease.
There is considerable variation in the management of mantle cell lymphoma across different clinical settings according to an analysis by investigators.
Post-operative atrial fibrillation may be a marker for early-stage heart failure and may potentially contribute to its development, according to a new study.
